TY  - GEN
AU  - Bongioanni,M R
AU  - Durelli,L
AU  - Ferrero,B
AU  - Imperiale,D
AU  - Oggero,A
AU  - Verdun,E
AU  - Aimo,G
AU  - Pagni,R
AU  - Geuna,M
AU  - Bergamasco,B
TI  - Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis
SN  - 0022-510X
PY  - 1997///0320
KW  - Antibodies
KW  - blood
KW  - Antigens, Surface
KW  - metabolism
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Cells, Cultured
KW  - chemistry
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Histocompatibility Antigens Class II
KW  - Humans
KW  - Immunoglobulin G
KW  - biosynthesis
KW  - Immunophenotyping
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Lymphocytes
KW  - cytology
KW  - Lymphokines
KW  - Macrophages
KW  - Male
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Neutralization Tests
KW  - Pilot Projects
KW  - Placebos
KW  - Recombinant Proteins
KW  - beta 2-Microglobulin
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0022-510x(96)00176-1
ER  -